Canary launches staking-enabled Injective ETF on Nasdaq
Canary’s INJC fund began trading with built-in staking and $16.12 million in assets after Injective’s CEO rang the Nasdaq bell.
Canary’s INJC fund began trading with built-in staking and $16.12 million in assets after Injective’s CEO rang the Nasdaq bell. Injective (INJ) is trading at ₹750 ($7.97), down 0.3% since this brief published. This is an original Token Times brief based on reporting by Crypto.news, with live market data added, as of Mon, 09 Nov 2026 11:00:01 UTC.
The launch gives investors a listed avenue for INJ exposure while incorporating staking into the product structure. Its early asset base and broader market conditions provide the first measured context for the new fund.
- Canary’s INJC staked Injective ETF began trading on Nasdaq on Nov. 5
- The fund held $16.12 million in assets by Friday
- INJ traded at $7.99, down 2.06% over 24 hours
- INJ gained 10.43% over seven days amid broad market weakness
- Injective Launches AI Compute Price Index and Perpetual Market SICI
- Injective Launches AI-Focused Futures Market Tracking Nvidia GPU Rental Costs
- Nasdaq Approves Listing of Canary Capital’s Staked INJ ETF
- Canary Capital’s Staking-Enabled Injective ETF Receives Nasdaq Approval
- Canary launches staking-enabled Injective ETF on Nasdaq — this brief
Injective’s CEO rang the Nasdaq bell as Canary’s INJC staked Injective ETF started trading on Nov. 5, according to Crypto.news. The launch combines listed access to Injective with staking functionality built into the product, marking a notable step for the network’s token within a traditional exchange-listed fund structure.
By Friday, the ETF held $16.12 million in assets and had 600,000 shares outstanding, Crypto.news reported. The available figures establish the fund’s initial reported scale, although the summary did not provide trading volume, share-price performance, fees, or the amount of INJ held or staked through the vehicle.
Canary’s product is specifically structured as a staked Injective ETF rather than a conventional ETF without staking. Its Nasdaq debut also follows a period in which INJ has performed differently from the wider crypto market: the token rose 10.43% over seven days even as the broader market was broadly lower. Future assets, share counts, and the size of any staking activity were not included in the supplied report.
Live market data showed INJ at $7.99, down 2.06% over 24 hours, with a market capitalization of $798.56 million. The total crypto market capitalization stood at $2.56T, while 
Bitcoin was down 1.62% over the same 24-hour period. The Fear & Greed index registered 29, placing sentiment in the “Fear” zone despite INJ’s positive seven-day result. The figures to monitor are the ETF’s subsequent asset and share growth alongside how INJ and the broader market move from this mixed backdrop.
Since this brief published about 4 hours ago, Injective (INJ) has moved from ₹751.44$7.99 to ₹749.56$7.97 — -0.25%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹796.88 (about $7.97), down 2.8% over 24 hours. The rupee itself trades about 6.3% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Canary launches staking-enabled Injective ETF on Nasdaq — questions & answers
When did Canary’s INJC ETF begin trading?
It began trading on Nasdaq on Nov. 5, according to Crypto.news.
How large was the ETF at launch?
By Friday, it held $16.12 million in assets and had 600,000 shares outstanding.
What distinguishes the INJC ETF from a conventional ETF?
The product has staking functionality built into its Injective exposure.
How much is 1 Injective worth in rupee today?
About ₹796.88 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $7.97. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is down 0.25% since this brief first published — trading at ₹750 ($7.97) now versus ₹751 ($7.99) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from Crypto.news. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.